ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976